Spoken Alpha
Calidi Biotherapeutics, Inc.
Calidi Biotherapeutics develops oncolytic virus therapies designed to treat cancer. The company's RedTail platform uses engineered vaccinia viruses that survive in the bloodstream to reach metastatic tumors, replicate selectively in cancer cells, and deliver genetic medicines like IL-15 to tumor sites.
Calidi Biotherapeutics, Inc.
Behavioral analysis
Disclosures
Extracted from Unknown source, 2026-08-30.
Transcripts
We index calls for roughly 3,000 US-listed companies. If you'd like us to add CLDWW, reply to your welcome email and we'll prioritize it.
History
Reported quarters with consensus, surprise, and 1-day reaction context.
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for CLDWW.
$ curl https://api.spokenalpha.com/v1/companies/CLDWWFAQ
Spoken Alpha indexes CLDWW's earnings call transcripts at https://spokenalpha.com/companies/CLDWW. Each call links to attributed speakers and parsed analyst Q&A. Calidi Biotherapeutics, Inc.'s own investor relations page is at https://ir.calidibio.com/overview/default.aspx.